In vivo corneal neovascularization imaging by optical-resolution photoacoustic microscopy  by Liu, Wenzhong et al.
Photoacoustics 2 (2014) 81–86Short Communication
In vivo corneal neovascularization imaging by optical-resolution
photoacoustic microscopy
Wenzhong Liu a, Kathryn M. Schultz b, Kevin Zhang a, Amy Sasman b,
Fengli Gao a,c, Tsutomu Kume b,*, Hao F. Zhang a,d,**
aDepartment of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA
b Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
c State Key Laboratory on Integrated Optoelectronics, College of Electronic Science and Engineering, Jilin University, Changchun 130012, China
dDepartment of Ophthalmology, Northwestern University, Chicago, IL 60611, USA
A R T I C L E I N F O
Article history:
Received 8 November 2013
Received in revised form 2 April 2014
Accepted 8 April 2014





A B S T R A C T
Corneal neovascularization leads to blurred vision, thus in vivo visualization is essential for pathological
studies in animal models. Photoacoustic (PA) imaging can delineate microvasculature and
hemodynamics noninvasively, which is suitable for investigating corneal neovascularization. In this
study, we demonstrate in vivo imaging of corneal neovascularization in the mouse eye by optical-
resolution photoacoustic microscopy (OR-PAM), where corneal neovascularization is induced by
deliberate alkali burn injuries in C57BL6/J inbred mice corneas on the left eye. We used OR-PAM to image
ﬁve mice with corneal alkali burn injuries; the uninjured eyes (right eye) in these mice are then used as
the controls. Corneal images acquired by OR-PAM with and without alkali burn injury are compared,
clear signs of corneal neovascularization are present in the OR-PAM images of injured eyes; the OR-PAM
results are also conﬁrmed by postmortem ﬂuorescence-labeled confocal microscopy.
 2014 The Author. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Normal corneal tissue is avascular in order to allow light to pass
through without being affected; the presence of blood vessels in
the cornea, usually as a result of corneal neovascularization, can
partially obstruct incoming light, leading to blurred vision. This
pathophysiology has been observed in humans most commonly as
a form of inﬂammatory response to an external insult [1] or as a
less common but more serious autoimmune response such as
Cogan’s syndrome [2]. Without treatment, the progression of
corneal neovascularization can completely block light from
entering the eye [3].
Visualization of the vascular cornea is important for a
pathological study of corneal neovascularization, as well as
monitoring its disease progression in animal models. Current
methods of visualizing corneal neovascularization in vivo include* Corresponding author at: Feinberg Cardiovascular Research Institute, Feinberg
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3.0/).slit lamp imaging [4,5] and confocal microscopy imaging [6]. Slit
lamp imaging can be performed with computerized color image
analysis [4] or with ﬂuorescent angiography [5]. Color image
analysis is subjective and therefore limited. Fluorescent angiogra-
phy, although repeatable, requires that subjects be tolerant to
injectable chemical dyes. Confocal microscopy imaging boasts high
resolution [7], but as a light scattering or ﬂuorescence contrast
based method, is not yet able to quantify the oxygen saturation
level within vessels, which is important for identifying the
progression of microvascular related diseases and viability of
the tissue [8].
One potential effective imaging modality for corneal neovas-
cularization visualization is photoacoustic microscopy (PAM),
which takes advantage of the strong optical absorption of
hemoglobin to image microvascular networks with a high image
contrast and high spatial resolution [9]. In PAM, short laser pulses
are directed into biological tissues [8,10,11,12,13]; when chromo-
spheres, such as hemoglobin and melanin, absorb optical energy,
thermoelastic vibration will be triggered in corresponding tissues
and as a result, generation of broadband ultrasonic waves occur
[10,12,14]. Such ultrasonic waves, carrying information of the
optical absorption properties, geometry, and location of local
tissues, can be detected for microscopic imaging; when multi-
wavelength illumination is used, PAM can also assess blood oxygenle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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associated with microvascular pathologies [15,16]. Recently,
applications of PAM have been demonstrated in cardiovascular
pathophysiologies [17,18,19], diabetes [20] brain trauma [21],
tumor angiogenesis [8,13,22] and iris vascular networks [23].
In this paper we report on the application of optical-resolution
PAM (OR-PAM) to image corneal neovascularization. We ﬁrst
deliberately induced corneal neovascularization in C57BL6/J
inbred mice by chemically burning the right cornea with an
alkaline solution [24]. Two weeks later, we subjected them to our
OR-PAM system for corneal imaging. We imaged the left eye of ﬁve
mice to gauge the progression of angiogenesis and used the
uninjured right eyes as controls. Clear signs of corneal neovascu-
larization were observed in the injured eyes using OR-PAM; but
not in the control eyes. The OR-PAM results were also conﬁrmed by
postmortem histological examination using ﬂuorescence confocal
microscopy.
2. Materials and methods
2.1. OR-PAM system
The schematic diagram of OR-PAM is shown in Fig. 1a. An
Nd:YAG laser (SPOT-10-200-532, Elforlight Ltd.; output wave-
length: 532 nm; pulse duration: 1 ns) served as the illumination
source. The laser output was delivered by a single-mode optical
ﬁber, further ﬁltered by a 75 mm diameter pinhole (P75S, Thorlabs)Fig. 1. Experimental OR-PAM system. (a) Schematic of the OR-PAM system; AMP: ampl
amplitude projection OR-PAM image of a USAF-1951 resolution target; (c) estimation o
difference.and collimated to 9 mm in diameter through a telescope system;
then the laser was focused by a microscope objective (PlanN4,
NA = 0.1, Olympus) onto the sample through a beam splitter cube
(reﬂectance/transmittance ratio: 70/30). Laser-induced ultrasonic
signals were ﬁrstly collimated coaxially with the illumination laser
light through a plano-concave lens (Diameter: 6.0 mm, Focal
length: 9 mm, Edmund Optics) attached to the bottom of the
beam-splitter cube; and then detected by an unfocused ultrasonic
transducer (V312, Olympus NDT; center frequency: 10 MHz;
bandwidth: 80%; active element diameter: 6 mm). The detected
PA signals were ampliﬁed by a wideband ampliﬁer (ZFL 500LN,
Mini-Circuits); then digitized and recorded by an acquisition board
(CS12400, Gage Applied) at a sampling rate of 400MS/s. During
imaging, the mouse was placed on an x–y motorized stage
(23H118S059, Danaher Motion). A custom-made water tank with a
window at the bottom (sealed by a thin plastic membrane) was
used for ultrasonic coupling between the mouse eye and detection.
To test the lateral resolution of our OR-PAM system, we imaged
a USAF resolution target (USAF-1951, Applied Image). The OR-PAM
system can resolve the fourth element of group 7 (Fig. 1b), which
corresponds to a lateral resolution of 2.76 mm and a Rayleigh
length of 11.5 mm at 532 nm. To determine the axial resolution, a
typical A-line (Fig. 1c) was used as the approximation of a 1D
acoustic axial point-spread-function (PSF). We shifted the 1D PSF
with a distance and added it back to the original PSF. We then
applied Rayleigh criterion to the sum, where the smallest shifted
distance capable of resolving two peaks in the sum (by a 10%iﬁer; UT: ultrasonic transducer; BS: beam splitter; AL: acoustic lens; (b) maximum
f axial resolution from a typical A-line acquired from USAF-1951 target. SD: shift
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As shown in Fig. 1c, the axial resolution for our OR-PAM system is
around 50 mm.
In our experiments, the laser pulse energy was 80 nJ. The
radiant exposure within the focal spot was 13.4 mJ/cm2, which was
within the maximum permissible exposure limit determined by
the American National Standards Institute (ANSI) [26]. The laser
induced temperature rise in biological tissue was estimated to be
on the order of milliKelvins (mK) [27], which is considered safe.
2.2. Anatomy of corneal structure and corneal neovascularization
As shown in Fig. 2, a typical health mouse cornea consists of an
avascular transparent structure in an arc shape located at the
foremost anterior segment of the eyeball. Parts of the anterior eye
adjacent to the cornea include the conjunctiva, iris, limbus and
sclera. The typical curvature of a mouse cornea is 1.4 mm [28], with
60 mm in thickness [28]. When the cornea becomes injured, there
exists abnormal growth of blood vessels from the limbus into the
adjacent corneal stroma as marked by the red arrows in Fig. 2. This
will most likely result in vision debilitation and obstruction.
2.2.1. Animal model preparation and corneal imaging
In an effort to elucidate the injury-mediated vascular out-
growth from the limbus into the cornea, we injured the wild-type
C57BL6/J mice corneas as previously described [29]. Brieﬂy, at 6-
weeks old, mice were anesthetized by intraperitoneal (IP) injection
of a solution of ketamine hydrochloride (80 mg/kg body weight;
Fort Dodge Animal Health) and xylazine (6 mg/kg body weight;
Lloyd Laboratories). The cornea was further desensitized with a
0.5% proparacaine hydrochloride ophthalmic solution (Bausch &
Laumb) for 1 minute. Then 2 mm disks soaked with 1-N sodium
hydroxide were placed on the cornea for 1 min. The corneas were
then ﬂushed with saline and treated with erythromycin ophthal-
mic ointment (Fougera) to prevent bacterial infections. At the 14th
day after injury, the corneas were imaged by OR-PAM, and then
harvested for histological analysis.
For corneal imaging, we ﬁrst anesthetized the mouse by an
intraperitoneal (IP) injection of a cocktail of Ketamine (87 mg/kg
body weight) and Xylazine (13 mg/kg body weight). We then
applied a 0.5% Tetracaine Hydrochloride ophthalmic solution to
paralyze the iris sphincter muscle. The anesthetized mouse was
restrained onto a motorized stage with a scanning step size of
2 mm. The PA illumination laser pulse repetition rate was 1 kHz.
We adjusted optical focal region to cover the limbus area in the
cornea because neovascularization always originates from the
limbal vascular plexus and then progresses toward the corneal
center [30]. We imaged a 3 mm  3 mm area to cover the wholeFig. 2. Diagram of corneal structure and corneal neovascularization. For a healthy
mouse cornea, there are no blood vessels; for an injured mouse cornea, there is
abnormal growth of blood vessels (marked by the red arrow) from the limbus into
the adjacent corneal stroma.mouse cornea. There are a total of 1500  1500 A-lines; each A-line
comprises 200 data points; and no signal averaging was used.
It took 20 min to acquire an image with a ﬁeld-of-view of
3 mm 3 mm, which covers the whole upper corneal surface of the
eye. During the imaging process, we used a lamp to keep the
mouse’s body warm. All of these experimental procedures were
approved by Northwestern University’s Institutional Animal Care
and Use Committee (IACUC) and conformed to the Association for
Research in Vision and Ophthalmology Statement on Animal
Research.
2.3. Immunostaining
Corneal immunostaining and ﬂat mounting was performed as
previously described [29]. Brieﬂy, enucleated eyes were ﬁxed in 4%
paraformaldehyde (PFA) for one hour at room temperature, rinsed
in PBS, and cut in half. The iris was removed from the cornea and
the cornea was cut radially to facilitate ﬂat mounting. The corneas
were placed in 100% methanol at 20 8C overnight before
immunostaining.
To detect blood and lymphatic vessels in ﬂat-mount immuno-
staining, the corneas were permeabilized with 1% Triton X-100/
PBS for 20 min, and blocked with 5% donkey serum (Sigma) for
20 minute, and then stained with anti-Lyve-1 antibodies (Abcam)
overnight at 4 8C. Corneas were then washed with 0.1% Tween 20/
PBS and then stained with PE-conjugated anti-CD31 (BD Bios-
ciences, clone MEC 13.3) and AlexaFluor488 donkey anti-rabbit IgG
(Invitrogen). Corneas were ﬂat mounted and images were collected
by a Zeiss Axio Observer D1 at 2.5.
3. Results
OR-PAM images were acquired from both injured and normal
wild-type C57BL6/J mouse eyes to examine the presence and
prevalence of corneal neovascularization. The acquired 3D OR-
PAM dataset was ﬁrst smoothed by a 3  3 median ﬁlter within
each B-scan to reduce background noise, then visualized through a
maximum amplitude projection (MAP) along each A-line to form a
2D projected image. Fig. 3a shows a 3 mm by 3 mm MAP image of
the whole volumetric data from an injured left eye. In Fig. 3a, the
corneal vessels are not clearly visible because of the strong PA
signals generated from the iris due to high melanin concentration,
which can be conﬁrmed by the cross-sectional OR-PAM B-scan
image. One sample OR-PAM B-scan image selected from the
highlighted position in Fig. 3a is shown in Fig. 3b, where the
melanin-rich iris, represented by the solid, circular-shaped surface
occupying the bottom half, is imaged below the corneal vessels
(highlighted by the arrow). There is no clear visualization of the
pupil in OR-PAM, as shown in Fig. 3a. One possibility could be due
to inﬂammation accompanying corneal vascularization, which
may prevent the pupil from being visible [31].
To better visualize the corneal vessels, we ﬁrst identiﬁed the
boundary of the iris by the strong optical absorption of the iris
melanin; then, we ﬁtted a smooth curve (as shown in Fig. 3b by the
red-line) within each B-scan image to separate the iris and cornea
vessels, ﬁnally we digitally removed the iris and conducted MAP
operation again to highlight only optical absorption from the
corneal vasculature. The result was showed in Fig. 3c, where a
densely-packed vascular network is clearly visualized.
We conﬁrmed our OR-PAM imaging results with histological
corneal examination. For simplicity, we merely demonstrated the
results from a small corneal region within the dash box labeled in
Fig. 3c. A magniﬁed view of selected blood vessels from the
dashed-box in Fig. 3c is shown in Fig. 3d, where arrows 1–3
highlight speciﬁc vessels of interest. The measured large vessel
diameter in Fig. 3d is 74  6.51 mm, and the small vessel diameter is
Fig. 3. Imaging results of an injured cornea. (a) Full-volume projection OR-PAM image; (b) B-scan image from the position highlighted in panel A. The overlaid red curve is the
boundary of pigment-rich tissue detected by an automatic algorithm; (c) Projection after segmentation; (d) magniﬁed view of the area enclosed by the dashed-box in panel c;
(e) histological image of the area shown in (d) acquired with anti-CD31 staining, which highlights blood and lymphatic vessels; (f) histological image of the area shown in (d)
stained with anti-Lyve-1 antibodies, which visualizes lymphatic vessels only; (g) fused CD31 and Lyve-1 histological images, where arrows highlight three vessels matching
with magniﬁed OR-PAM image shown in panel D. Bar: 200 mm.
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Fig. 3e, where the cornea sample was stained with PE-conjugated
anti-CD31, the image was produced at a resolution of 2 mm using a
commercial microscope. Since anti-CD31 highlights both blood and
lymphatic vessels, a second stain was performed with anti-Lyve-1
antibodies to capture only the lymphatic vessels, which is shown in
Fig. 3f. The overlaid CD31 and Lyve-1 image is shown in Fig. 3g, where
the three highlighted vessels exhibit matching branching patterns as
seen in Fig. 3d.
The images from a control mice cornea are shown in Fig. 4. For
the healthy mice cornea, in the OR-PAM image, we can observe a
dark vascular network in a bright background, which are iris
vessels (highlighted by arrows) embedded in a highly pigmented
background (Fig. 4a). A detailed B-scan of the normal cornea is
given in Fig. 4b obtained at the position highlighted in Fig. 4a.Unlike what we can observe in Fig. 3b, there is only a continuous
melanin-rich layer without any vessels present above it in Fig. 4b.
The two arrows in Fig. 4b highlight shadows created by two iris
vessels that can also be seen in Fig. 4a. Histological examination
with anti-CD31 further conﬁrmed the lack of corneal vasculariza-
tion (Fig. 4c).
4. Discussion and conclusion
In this report we applied OR-PAM for cornea vascular imaging.
OR-PAM leverages only the endogenous light absorbers in the
tissue, so it is totally label free, and therefore needs no chemical
dye for vascular imaging. Furthermore, with multiple wavelength
imaging, the oxygen saturation could be precisely quantiﬁed
through OR-PAM [21]. In the present study, where for preliminary
Fig. 4. Imaging results of a control eye. (a) Full-volume projection OR-PAM image, where pupil and iris vascular networks can be observed; (b) B-scan image from the location
highlighted in panel A. The arrows point out shadows created by iris vessels; (c) Histological image of the whole cornea with anti-CD31 staining, which shows no blood and
lymphatic vessels. Scale bar: 200 mm.
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network imaging, we demonstrated, for the ﬁrst time, OR-PAM
imaging of alkali-burn-injured mouse eyes in vivo. Using OR-PAM,
both injured and control eyes were imaged, where we clearly
visualized vascular invasions into the cornea as a result of injury,
further conﬁrmed by histology. Additionally, the imaging laser
pulse energy was measured to be 80 nJ, which is safe for mice eye
imaging [26].
Visualization of the vascular network in the cornea in vivo can
be important for studying the mechanism of corneal neovascular-
ization. Comparison with previously tested imaging modalities for
corneal neovascularization [4–6], OR-PAM can achieve a similar
lateral resolution as confocal microscopy, while requiring no
contrast agent in both anatomical and functional imaging of
microvascular networks. OR-PAM can obtain a volumetric image
from a two-dimensional scan combined with time-resolved
ultrasonic detection. In comparison, confocal microscopy needs
a three-dimensional scan to acquire the same volumetric image.
More importantly, OR-PAM has the capability to quantify vascular
oxygen saturation noninvasively, which will open up new
possibilities in corneal angiogenesis research.
Another potential alternative for corneal neovascularization
network mapping and visualization is optical coherence tomogra-
phy (OCT) [32], which boasts high axial resolution, high speed,
non-contact imaging, and capabilities of mapping micro-vessels in
tissue through phase or speckle variance contrast. However, one of
the key parameters involved in neovasculature development is the
hypoxic environment [33], where variations in vessel sO2 are still
beyond the reach of existing OCT. These changes currently can only
be measured precisely using photoacoustic microscopy [8,13,20],
which is the motivation of this work.
There are a few limits of OR-PAM corneal neurovascular
imaging. The micro-vessels span almost the entire region of the
cornea, yet vascular discontinuity was observed at the corneal
center as shown in Fig. 3c. This is caused by the limited imaging
depth of our current OR-PAM system and the large depth variation
of the corneal vessels. The imaging depth of our OR-PAM is
700 mm, while the depth variation of corneal vessels can be more
than 1.4 mm owing to the curvature of the mouse cornea [28]. Such
a depth range was much larger than the imaging depth of our
system. During imaging, we adjusted the optical focal region to
cover the area around the corneal limbus because neovasculariza-
tion originates from the limbal vascular plexus and progresses
toward the central cornea [30], as a result, we observed clear
vasculature in the limbal areas but vascular discontinuities at or
near the cornea center. To compensate for such a large depth
variation due to sample curvature, we can employ a z-axis scan in
the system as previously reported. [34]In addition, there are several aspects that can be further reﬁned
for future studies. To improve the spatial resolution to image ﬁner
vascular network, we plan to employ ultrasonic transducers with
higher center frequencies (75 MHz) to achieve ﬁner lateral
ultrasonic focusing. We can potentially integrate ﬂuorescence
confocal microscopy into OR-PAM [35,36] to image both corneal
vascular and lymphatic networks at the same time after delivering
an appropriate ﬂuorescent dye into the lymphatic system.
Moreover, we plan to apply multi-wavelength OR-PAM to assess
the blood oxygen saturation, and further monitor the develop-
mental progress of corneal neovascularization over time in rodent
models. After achieving the proposed improvements, this novel
technique will allow us to visualize corneal neovascularization in
knockout animals to elucidate the underlying mechanisms of
neovascularization and eventually provide guidance in treating
human patients.
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